SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-003569
Filing Date
2021-02-12
Accepted
2021-02-12 11:36:09
Documents
14
Period of Report
2021-02-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 34056
2 ex99-1.htm EX-99.1 29113
3 ex99-1_001.jpg GRAPHIC 4188
  Complete submission text file 0001493152-21-003569.txt   250181

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE abeo-20210212.xsd EX-101.SCH 2787
5 XBRL LABEL FILE abeo-20210212_lab.xml EX-101.LAB 34592
6 XBRL PRESENTATION FILE abeo-20210212_pre.xml EX-101.PRE 22731
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3615
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 21624405
SIC: 2834 Pharmaceutical Preparations